Trials / Terminated
TerminatedNCT06084676
Organoid Model Predictive of Response to Immunotherapies
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 1 (actual)
- Sponsor
- Indiana University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to create models out of tissue samples and treat those models with the same immunotherapy treatment the patient will be receiving, in order to validate this process and to predict responses to therapies and use it to choose the best treatments for people in the future. The researchers will then examine the direct effects of the treatment on those models.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Immunotherapy | Organoid samples will be collected at time of biopsy and cultured in the lab. The samples will then receive the same standard of care immunotherapy treatment as the patient. |
Timeline
- Start date
- 2024-01-22
- Primary completion
- 2024-02-26
- Completion
- 2024-02-26
- First posted
- 2023-10-16
- Last updated
- 2024-07-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06084676. Inclusion in this directory is not an endorsement.